Mike Marciniak

Senior Director, Business Development US

Mike Marciniak is Director of Business Development, North America, for Single Use Support. In this role he seeks opportunity to advance bioprocessing by sharing the values of the novel process technologies offered by Single Use Support. Mike mainly advises on fluid management topics with focus and expertise on freeze-thaw, process intensification, and frozen storage & logistics for high-value drug substances and new bulk drug products. He is a long-time member of ISPE, PDA and the ASME.

With his more than 20-years’ experience in the biopharmaceutical industry, serving in a variety of roles including quality, engineering, innovation, product management and technical sales, he served 8-years as Senior Global Product Manager at Sartorius directing their freeze-thaw technology portfolio. After that, Mike went on to develop advanced passive shipping solutions for specialty cold chain packaging for novel therapeutics.

His education focused on thermal sciences culminating with an MS in Nuclear Engineering from the University of Illinois-Urbana/Champaign. 

Articles written by Mike Marciniak

July 25, 2022

Pharmaceutical cold chain management – from cold to ultra-cold: An overview of all freezing ranges

Temperature plays a significant role in the production and distribution of several revolutionary biologics. But how does the pharmaceutical cold chain work, and what temperature ranges are most frequently chosen? You will find out in this article!

July 7, 2022

Fluid management in biopharma: Advantages of single-use systems

Major changes in biopharma industry require new approaches along the supply chain of most innovative biologics – including fluid management. Here's to discover how single-use products help to achieve considerable improvements.

July 4, 2022

AAV production workflow – where do we come in?

The production of AAVs requires to fulfill high standards and is thus in need of state of the art technologies. Find out what the key elements in the production of AAVs are and how our products help to carry them out.

July 4, 2022

Safe handling of AAVs

Adeno-associated viruses are an increasingly important tool in biopharma, used for example as vectors for gene therapy and vaccines. But how are they adequately – and safely – handled? Here are some key aspects to consider along their supply chain.